P1440: BTK INHIBITORS IMPROVE CART19 CELL THERAPY BY MODULATING IMMUNE SYSTEM

• W. Luo,
• C. Li,
• M. Du,
• F. Zhou,
• Y. Zhang,
• L. Tang,
• J. Wu,
• H. Jiang,
• Q. Wei,
• C. Lu,
• H. Kou,
• H. Mei,
• Y. Hu

Affiliations

W. Luo

1 Institute of Hematology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

C. Li

1 Institute of Hematology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

M. Du

1 Institute of Hematology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

F. Zhou

2 Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease

Y. Zhang

1 Institute of Hematology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

L. Tang

1 Institute of Hematology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

J. Wu

1 Institute of Hematology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

H. Jiang

1 Institute of Hematology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Q. Wei

1 Institute of Hematology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

C. Lu

1 Institute of Hematology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

H. Kou

1 Institute of Hematology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

H. Mei

1 Institute of Hematology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Y. Hu

1 Institute of Hematology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology